Reports for FRESENIUS KABI CANADA LTD
Company Name FRESENIUS KABI CANADA LTD |
||
|---|---|---|
Totals |
||
Shortage reports |
341 |
|
| Actual shortage: | 5 (1%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 5 (1%) | |
| Resolved: | 331 (97%) | |
Discontinuation Reports |
2 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 2 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
51 (15%) |
|
Overdue reports |
3 (60%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MIDAZOLAM INJECTION | 5MG | LIQUID | Resolved | 2021-12-17 | 2022-03-19 | 151515 |
| MIDAZOLAM INJECTION | 5MG | LIQUID | Resolved | 2022-04-13 | 2022-05-01 | 158771 |
| MIDAZOLAM INJECTION | 5MG | LIQUID | Avoided shortage | 2022-04-28 | 2022-06-01 | 159557 |
| MIDAZOLAM INJECTION | 5MG | LIQUID | Resolved | 2023-01-02 | 2023-04-03 | 179688 |
| MILRINONE LACTATE INJECTION | 1.0MG | SOLUTION | Resolved | 2017-03-15 | 2017-04-08 | 2996 |
| MILRINONE LACTATE INJECTION, USP | 1MG | SOLUTION | Resolved | 2021-10-27 | 2021-11-11 | 148301 |
| MILRINONE LACTATE INJECTION, USP | 1MG | SOLUTION | Resolved | 2022-03-31 | 2022-05-02 | 157676 |
| MILRINONE LACTATE INJECTION, USP | 1MG | SOLUTION | Resolved | 2022-07-07 | 2022-08-03 | 164276 |
| MILRINONE LACTATE INJECTION, USP | 1MG | SOLUTION | Resolved | 2022-07-07 | 2022-08-03 | 164279 |
| MILRINONE LACTATE INJECTION, USP | 1MG | SOLUTION | Resolved | 2022-08-04 | 2022-11-02 | 166127 |
| MILRINONE LACTATE INJECTION, USP | 1MG | SOLUTION | Resolved | 2022-08-04 | 2022-08-25 | 166152 |
| MILRINONE LACTATE INJECTION, USP | 1MG | SOLUTION | Resolved | 2022-08-24 | 2022-11-02 | 167705 |
| MILRINONE LACTATE INJECTION, USP | 1MG | SOLUTION | Resolved | 2022-11-07 | 2023-04-03 | 173929 |
| MILRINONE LACTATE INJECTION, USP | 1MG | SOLUTION | Resolved | 2022-11-07 | 2023-04-03 | 173932 |
| MILRINONE LACTATE INJECTION, USP | 1MG | SOLUTION | Resolved | 2023-11-01 | 2024-04-23 | 208900 |
| MITOXANTRONE INJECTION | 2MG | SOLUTION | Resolved | 2020-04-20 | 2020-05-06 | 112481 |
| MORPHINE SULFATE INJECTION, USP | 10MG | SOLUTION | Actual shortage | 2025-04-03 | 2025-04-26 | 253988 |
| MORPHINE SULFATE INJECTION, USP | 10MG | SOLUTION | Resolved | 2021-10-27 | 2021-12-17 | 148318 |
| MORPHINE SULFATE INJECTION, USP | 2MG | SOLUTION | Resolved | 2024-11-20 | 2025-01-08 | 243494 |
| MORPHINE SULFATE INJECTION, USP | 2MG | SOLUTION | Resolved | 2021-09-24 | 2021-10-06 | 146195 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 4.5G 36G | POWDER FOR SOLUTION | Discontinued | 2024-08-13 | 2024-08-20 | 235203 |
| SODIUM BICARBONATE INJECTION, USP | 42MG | SOLUTION | Discontinued | 2024-10-03 | 2024-10-03 | 239180 |
Showing 1 to 2 of 2